Category Archives: Manufacturing

EU Steps Up Manufacturing Inspection Efforts

One of EMA’s key objectives this year is improvements in dealing with the “causes and impact of shortages of human medicines caused by GMP non-compliance and quality defects”. The European Directorate for the Quality of Medicines & Healthcare, which is responsible for the European Pharmacopoeia but also runs its own inspection operations, has been tightening […]
Also posted in Europe, Guest Blog, Regulatory | Tagged , , , , | Leave a comment

Turkey to See Renewed Multinational Investment, Says Report

Turkey is remains a key destination for foreign investment, and the next five years should see renewed interest from pharma multinationals, says a new report by CPhI Worldwide. Although the Turkish government’s price referencing system and fixed euro-lira conversion rate have presented a major obstacle for pharma growth, the report states that these pricing challenges […]
Also posted in Emerging Markets, Europe, Global, pricing, R&D | Tagged , , | Leave a comment

Paying for the Future of Medicine

Is the hallmark of innovation higher drug prices? The three leading justifications for sticker-shocking drug prices in the US, from the biopharma perspective, are: 1) it costs a lot to bring a drug to market;* 2) drugs – even very expensive ones – are cheaper in the long run since they prevent complications, hospitalizations and […]
Also posted in Biotech, FDA, healthcare, leadership, Market Access, pricing, R&D, Regulatory, Technology | Tagged , , , , , , | 1 Comment

Antibiotics Discovery: Time for a ‘Manhattan Project’

by Susan Crowley The innovative pharmaceutical industry is under attack from critics around the world for failing to develop new antibiotics to treat emerging infections. The charge has been furthered by statements from World Health Organization (WHO) director Margaret Chan. In 2012, she warned that bacteria were starting to become so resistant to common antibiotics […]
Also posted in Corporate Responsibility, Global, Guest Blog, healthcare, IP, leadership, Market Access, R&D, Strategy | Tagged , , , , , , , | 4 Comments

M&As and IPOs Shake Up CMO Industry

The CMO industry is undergoing a wave of ownership changes, including acquisitions, divestitures, and initial public offerings (IPOs). Ownership changes can lead to significant changes in a company’s strategy, focus, and prospects, so it is important for bio/pharmaceutical companies to review the implications of a key supplier’s change in ownership, writes Jim Miller. Recently announced […]
Also posted in Deals | Tagged , , , | Leave a comment
  • Categories

  • Meta